Sharmistha Ghosh
Galgotias University
H-index: 47
Asia-India
Top articles of Sharmistha Ghosh
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Analysis of reservoir outflow using deep learning model | Modeling Earth Systems and Environment | Surendra Singh Choudhary SK Ghosh | 2024/2 |
P190 Delayed IBD diagnosis leads to worse outcomes over years, with multiple implications on service delivery | Journal of Crohn's and Colitis | A Rao A Bazarova P Mitra S Majumder T Parigi | 2023/2/1 |
P553 Active tuberculosis and opportunistic infections: Pooled safety analysis of ustekinumab through up to 5 years across all approved indications | Journal of Crohn's and Colitis | S Ghosh M Long E Ott C Gasink T Baker | 2023/2/1 |
P773 Extended induction in the True North open-label extension study: clinical outcomes of~ 2 years of ozanimod treatment | Journal of Crohn's and Colitis | S Vermeire JF Colombel MV Chiorean S Ghosh A Jain | 2023/2/1 |
OC. 02.1 ANASTOMOTIC TECHNIQUE DRIVES ENDOSCOPIC RECURRENCE IN POST-OPERATIVE CROHN'S DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS | OM Nardone G Luglio M Giglio G Calabrese F Castiglione | 2023/3/1 | |
973 Plastering Skills and Experience Among Junior Orthopaedic Doctors | British Journal of Surgery | S Dellis M Shabeer S Ghosh A Robinson | 2023/9 |
Corrigendum to ‘Glomerular filtration rate estimation for carboplatin dosing in patients with gynaecological cancers’:[ESMO Open volume 7 (2022) 10.1016/j. esmoop. 2022.100401] | ESMO open | A Samani R Bennett K Eremeishvili F Kalofonou S Whear | 2023/6/1 |
P122 External validation of the Picasso Histological Remission Index (PHRI) to assess endoscopic and histological remission and predict long-term outcome in Ulcerative Colitis … | Journal of Crohn's and Colitis | TL Parigi R Cannatelli OM Nardone I Zammarchi U Shivaji | 2023/2/1 |
P699 Ustekinumab therapy after biologic failure in patients with Crohn’s Disease–A real-world single centre experience | Journal of Crohn's and Colitis | S Majumder A Bazarova T Lorenzo Parigi M Love J Davis | 2023/2/1 |
A273 INCREASING THE REPRESENTATION OF INDIANS IN MICROBIOME RESEARCH: HOW DOES THEIR GUT MICROBIOME DIFFER? | Journal of the Canadian Association of Gastroenterology | LD D'Aloisio C McComb V Shetty M Ballal S Ghosh | 2023/3 |
Development of web GIS based accident information system for safe and sustainable transport | Materials Today: Proceedings | Sandeep Gupta Sanjeev Suman Subir Kumar Sharma PK Garg SK Ghosh | 2023/8/19 |
P715 Achievement and maintenance of endoscopic, histologic, and combined outcomes after extended induction in Week 10 nonresponders of ozanimod: 2-year interim analysis of the … | Journal of Crohn's and Colitis | S Vermeire JF Colombel DT Rubin S Ghosh A Jain | 2023/2/1 |
The implementation of a national online teaching platform for UK trainee otolaryngologists | The Bulletin of the Royal College of Surgeons of England | FR Green NW Wahid EA How Hong A Yao S Bola | 2023/6 |
P209 Delayed IBD diagnosis increases risk of requiring biologics in first 4-years-an Inception cohort study | Journal of Crohn's and Colitis | A Rao A Bazarova P Mitra T Parigi S Majumder | 2023/2/1 |
On behalf of Gastrointestinal Nutri-tion Core Group.(2023). Nutrition in GI Cancer: A Review | S Gupta SK Ghosh | 2023/1/29 | |
P756 Cumulative adverse events of anti-TNF therapy in IBD patients at a large tertiary centre–a 13-year real-world experience | Journal of Crohn's and Colitis | S Majumder M Love J Davis N Sharma M Nabil Quraishi | 2023/2/1 |
A70 FECAL-ADHERENT MUCUS IS A NON-INVASIVE SOURCE OF PRIMARY HUMAN MUC2 FOR STRUCTURAL AND FUNCTIONAL CHARACTERIZATION IN HEALTH AND DISEASE | Journal of the Canadian Association of Gastroenterology | N Fancy M Melvin N Kazemian L D’Aloisio S Davidson-Hunt | 2023/3 |
Factors influencing and changes in childhood vaccination coverage over time in Bangladesh: a multilevel mixed-effects analysis | BMC Public Health | Satyajit Kundu Subarna Kundu Abdul-Aziz Seidu Joshua Okyere Susmita Ghosh | 2023/5/11 |
Efficacy of etrasimod at Week 52 among patients with clinical response at Week 12 compared with the overall ulcerative colitis population: post hoc analysis of the phase 3 … | Zeitschrift für Gastroenterologie | B Siegmund S Vermeire BE Sands MC Dubinsky BG Feagan | 2023/8 |
OP39 Safety of ustekinumab in IBD: Final pooled long-term safety analysis through 5 years in CD and 4 years in UC | Journal of Crohn's and Colitis | S Ghosh B Feagan E Ott C Gasink C Marano | 2023/2/1 |
